tissue banks


Summary: Centers for acquiring, characterizing, and storing organs or tissue for future use.

Top Publications

  1. Secko D, Preto N, Niemeyer S, Burgess M. Informed consent in biobank research: a deliberative approach to the debate. Soc Sci Med. 2009;68:781-9 pubmed publisher
    ..In this context, there was persistent disagreement about when consent was required for new research activities. ..
  2. O Doherty K, Hawkins A. Structuring public engagement for effective input in policy development on human tissue biobanking. Public Health Genomics. 2010;13:197-206 pubmed publisher
    ..This is illustrated using a practical example involving a public engagement conducted to inform institutional policy for biobanking in British Columbia, Canada. ..
  3. Parker L. Using human tissue: when do we need consent?. J Med Ethics. 2011;37:759-61 pubmed publisher
  4. Hall M, King N, Perdue L, Hilner J, Akolkar B, Greenbaum C, et al. Biobanking, consent, and commercialization in international genetics research: the Type 1 Diabetes Genetics Consortium. Clin Trials. 2010;7:S33-45 pubmed publisher
    ..6) Allowing potential commercial uses of donated samples is controversial in some Asian countries. (7) Obtaining government approvals can be labor-intensive and time-consuming, and can require legal and diplomatic skills. ..
  5. Shickle D, Griffin M, El Arifi K. Inter- and intra-biobank networks: classification of biobanks. Pathobiology. 2010;77:181-90 pubmed publisher
    ..Thus, this proposed classification system should help better understand these issues and identify solutions. ..
  6. Johnsson L, Helgesson G, Rafnar T, Halldorsdottir I, Chia K, Eriksson S, et al. Hypothetical and factual willingness to participate in biobank research. Eur J Hum Genet. 2010;18:1261-4 pubmed publisher
    ..The value of surveys in assessing factual willingness may thus be limited. ..
  7. Litton J. Biobank informatics: connecting genotypes and phenotypes. Methods Mol Biol. 2011;675:343-61 pubmed publisher
  8. Brandsma M, van Ommen G, Wijmenga C, Kiemeney L. [Dutch government invests in existing biobanks]. Ned Tijdschr Geneeskd. 2010;154:A2825 pubmed
    ..Other major Dutch initiatives are String of Pearls and LifeLines. Together these will create the conditions needed for Dutch researchers to further develop their strong position in the international biobanking field. ..
  9. Sheldon E, Vo K, McIntire R, Aghajanova L, Zelenko Z, Irwin J, et al. Biobanking human endometrial tissue and blood specimens: standard operating procedure and importance to reproductive biology research and diagnostic development. Fertil Steril. 2011;95:2120-2, 2122.e1-12 pubmed publisher
    ..The detail and perspective in this SOP also provides a blueprint for implementation of similar collection programs at other institutions. ..

More Information


  1. De Corte P, Verween G, Verbeken G, Rose T, Jennes S, De Coninck A, et al. Feeder layer- and animal product-free culture of neonatal foreskin keratinocytes: improved performance, usability, quality and safety. Cell Tissue Bank. 2012;13:175-89 pubmed publisher
    ..These optimisations have significantly increased the performance, usability, quality and safety of our allografts. This paper describes, in detail, our current cryopreserved allograft production process. ..
  2. Hoeyer K. The ethics of research biobanking: a critical review of the literature. Biotechnol Genet Eng Rev. 2008;25:429-52 pubmed
    ..It points to the clear discrepancy between the concerns of donors, legislators and ethicists. The academic debate and legislatory action tend to focus on informed consent, and most of the concerns that donors have remain unattended to. ..
  3. Shaw P, Patterson S. The value of banked samples for oncology drug discovery and development. J Natl Cancer Inst Monogr. 2011;2011:46-9 pubmed publisher
  4. Longstaff H, Burgess M. Recruiting for representation in public deliberation on the ethics of biobanks. Public Underst Sci. 2010;19:212-24 pubmed
    ..Results presented here should allow the reader to critically examine our team's choices and could also be used to assist advocates of deliberative democracy and others who may wish to propose similar events in the future. ..
  5. Hawkins A. Biobanks: importance, implications and opportunities for genetic counselors. J Genet Couns. 2010;19:423-9 pubmed publisher
  6. Morrell B, Lipworth W, Axler R, Kerridge I, Little M. Cancer as rubbish: donation of tumor tissue for research. Qual Health Res. 2011;21:75-84 pubmed publisher
    ..We believe our data provides sufficient justification for an approach to regulation of tumor banking that is aimed at fostering a relationship based on the notions of virtuous reassignment and social exchange. ..
  7. Morales Pedraza J, Lobo Gajiwala A, Martínez Pardo M. A review of the International Atomic Energy Agency (IAEA) international standards for tissue banks. Cell Tissue Bank. 2012;13:15-25 pubmed publisher
    The IAEA International Standards for Tissue Banks published in 2003 were based on the Standards then currently in use in the USA and the European Union, among others, and reflect the best practices associated with the operation of a ..
  8. Collyar D. Biospecimens and people: a fundamental connection. J Natl Cancer Inst Monogr. 2011;2011:41-2 pubmed publisher
    ..Definitions of biospecimens and the importance to the research community and the public are included, as are conditions that caused the impetus of the caHUB. ..
  9. Riegman P, Van Veen E. Biobanking residual tissues. Hum Genet. 2011;130:357-68 pubmed publisher
    ..Respecting these form the basis of what can and cannot be done in the country where the research on the samples is being performed. ..
  10. Fraga A, Sukoyan M, Rajan P, Braga D, Iaconelli A, Franco J, et al. Establishment of a Brazilian line of human embryonic stem cells in defined medium: implications for cell therapy in an ethnically diverse population. Cell Transplant. 2011;20:431-40 pubmed publisher
    ..011% of those individuals. Our results highlight the challenges involved in hES cell banking for populations with a high degree of ethnic admixture. ..
  11. Beskow L, Friedman J, Hardy N, Lin L, Weinfurt K. Developing a simplified consent form for biobanking. PLoS ONE. 2010;5:e13302 pubmed publisher
  12. Kirkland M. The precautionary principle: a double edged sword?. Cell Tissue Bank. 2010;11:217-24 pubmed publisher
    ..This paper will focus on the application of the Precautionary Principle in the area of blood and tissues, which encompasses the burgeoning field of cellular therapies. ..
  13. Giesbertz N, Bredenoord A, van Delden J. Inclusion of residual tissue in biobanks: opt-in or opt-out?. PLoS Biol. 2012;10:e1001373 pubmed publisher
    ..We suggest that further interdisciplinary debate should answer the question when to opt-in or when to opt-out. ..
  14. Millar T, Walker R, Arango J, Ironside J, Harrison D, MacIntyre D, et al. Tissue and organ donation for research in forensic pathology: the MRC Sudden Death Brain and Tissue Bank. J Pathol. 2007;213:369-75 pubmed
    ..The potential for acquisition of normal CNS and non-CNS tissues and of various hard-to-get CNS disorders suggests that efforts to access the forensic post mortem service for research material are eminently worthwhile...
  15. Hansson M. For the safety and benefit of current and future patients. Pathobiology. 2007;74:198-205 pubmed
    ..In this article I argue that a 'safety principle' should have priority and suggest how this could be implemented in clinical practice and in association with biomedical research. ..
  16. McHale J, Habiba M, Dixon Woods M, Cavers D, Heney D, Pritchard Jones K. Consent for childhood cancer tissue banking in the UK: the effect of the Human Tissue Act 2004. Lancet Oncol. 2007;8:266-72 pubmed
  17. Johnsson L, Hansson M, Eriksson S, Helgesson G. Patients' refusal to consent to storage and use of samples in Swedish biobanks: cross sectional study. BMJ. 2008;337:a345 pubmed publisher
    ..A system of presumed consent with straightforward opt out would correspond with people's attitudes, as expressed in their actions, towards biobank research. ..
  18. Schmitt A, Bauer M, Heinsen H, Feiden W, Falkai P, Alafuzoff I, et al. How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II. J Neural Transm (Vienna). 2007;114:527-37 pubmed
    ..These guidelines may be of value for future implementations of additional neuropsychiatric brain banks world-wide. ..
  19. Grinberg L, Ferretti R, Farfel J, Leite R, Pasqualucci C, Rosemberg S, et al. Brain bank of the Brazilian aging brain study group - a milestone reached and more than 1,600 collected brains. Cell Tissue Bank. 2007;8:151-62 pubmed
  20. Pentz R, Billot L, Wendler D. Research on stored biological samples: views of African American and White American cancer patients. Am J Med Genet A. 2006;140:733-9 pubmed
    ..These findings support the recommendation to offer individuals a simplified consent with a one-time binary choice whether to provide biological samples for future research. ..
  21. Savulescu J. No consent should be needed for using leftover body material for scientific purposes. Against. BMJ. 2002;325:648-51 pubmed
  22. Bell W, Sexton K, Grizzle W. Organizational issues in providing high-quality human tissues and clinical information for the support of biomedical research. Methods Mol Biol. 2010;576:1-30 pubmed publisher
    ..Tissues should be collected, processed, and stored uniformly. Some tissues are provided to investigators from tissue banks for which tissues have been collected and processed according to standard operating procedures (SOPs) of the ..
  23. Qualman S, France M, Grizzle W, LiVolsi V, Moskaluk C, Ramirez N, et al. Establishing a tumour bank: banking, informatics and ethics. Br J Cancer. 2004;90:1115-9 pubmed
    ..Increasing molecular genetics testing is also resulting in an increased demand for high-quality nucleic acids. ..
  24. Fitzpatrick P, McKenzie K, Beasley A, Sheehan J. Patients attending tertiary referral urology clinics: willingness to participate in tissue banking. BJU Int. 2009;104:209-13 pubmed publisher
    ..This study indicates that patients want to support research and become willing partners in the battle against cancer. ..
  25. Hansson M, Dillner J, Bartram C, Carlson J, Helgesson G. Should donors be allowed to give broad consent to future biobank research?. Lancet Oncol. 2006;7:266-9 pubmed
  26. Forsberg J, Hansson M, Eriksson S. Changing perspectives in biobank research: from individual rights to concerns about public health regarding the return of results. Eur J Hum Genet. 2009;17:1544-9 pubmed publisher
    ..This calls for a shift of focus from autonomy and individual rights toward collective responsibility and solidarity. ..
  27. O Doherty K, Burgess M. Engaging the public on biobanks: outcomes of the BC biobank deliberation. Public Health Genomics. 2009;12:203-15 pubmed publisher
    ..In particular, we make the case for distinguishing between deliberative outputs of public engagement and analytical outputs that are the product of social scientific analyses of such engagements. ..
  28. Patel A, Gilbertson J, Parwani A, Dhir R, Datta M, Gupta R, et al. An informatics model for tissue banks--lessons learned from the Cooperative Prostate Cancer Tissue Resource. BMC Cancer. 2006;6:120 pubmed
    ..in molecular biology and growing requirements from biomarker validation studies have generated a need for tissue banks to provide quality-controlled tissue samples with standardized clinical annotation...
  29. Vermeulen E, Schmidt M, Aaronson N, Kuenen M, van der Valk P, Sietses C, et al. Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment. J Clin Pathol. 2009;62:275-8 pubmed publisher
    ..Patients prefer an opt-out plus procedure that includes the provision of explicit, verbal and written information. Less than 5% of patients decline to consent to the use of their stored tissue for research purposes. ..
  30. Hoeyer K. The power of ethics: a case study from Sweden on the social life of moral concerns in policy processes. Sociol Health Illn. 2006;28:785-801 pubmed
    ..However, their perceptions of trust, fairness and what it is that needs protection differ significantly. I conclude by considering the implications of variances in moral perspectives for the social study of ethics. ..
  31. Mroz T, Joyce M, Steinmetz M, Lieberman I, Wang J. Musculoskeletal allograft risks and recalls in the United States. J Am Acad Orthop Surg. 2008;16:559-65 pubmed
    There have been several improvements to the US tissue banking industry over the past decade. Tissue banks had limited active government regulation until 1993, at which time the US Food and Drug Administration began regulatory oversight ..
  32. Mohanty S, Mistry A, Amin W, Parwani A, Pople A, Schmandt L, et al. The development and deployment of Common Data Elements for tissue banks for translational research in cancer - an emerging standard based approach for the Mesothelioma Virtual Tissue Bank. BMC Cancer. 2008;8:91 pubmed publisher
    ..validation studies have catalyzed changes in the landscape of cancer research, fueling the development of tissue banks for translational research...
  33. Asslaber M, Zatloukal K. Biobanks: transnational, European and global networks. Brief Funct Genomic Proteomic. 2007;6:193-201 pubmed
  34. Axler R, Irvine R, Lipworth W, Morrell B, Kerridge I. Why might people donate tissue for cancer research? Insights from organ/tissue/blood donation and clinical research. Pathobiology. 2008;75:323-9 pubmed publisher
    ..While more research is necessary, a better understanding of the factors that motivate patients to give or refuse consent to tumour banking may ultimately improve consent practices, public trust and donation rates. ..
  35. van Veen E, Riegman P, Dinjens W, Lam K, Oomen M, Spatz A, et al. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer. 2006;42:2914-23 pubmed
    ..This coordinating rule has a sound basis in EU law in general and will solve the problems related to diverging national regulatory regimes in the case of cross national research with residual tissue. ..
  36. Vermeulen E, Schmidt M, Aaronson N, Kuenen M, Baas Vrancken Peeters M, van der Poel H, et al. A trial of consent procedures for future research with clinically derived biological samples. Br J Cancer. 2009;101:1505-12 pubmed publisher
    ..The 'opt-out plus' procedure, which places fewer demands on administrative resources than 'one-time consent', can also address the information needs of patients. ..
  37. Monoranu C, Apfelbacher M, Grunblatt E, Puppe B, Alafuzoff I, Ferrer I, et al. pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol. 2009;35:329-337 pubmed publisher
    ..pH measurement in brain tissue is a good indicator of premortem events in brain tissue and it signals limitations for post mortem investigations. ..
  38. Lefrere J, Coudurier N. [Biobanks and blood transfusion in France: a tool for public health]. Transfus Clin Biol. 2009;16:148-51 pubmed publisher
    ..Preserved over a long period of time, such transfusion biobanks will be useful in terms of public health, as a reflection of the biological state of a population at a given moment. ..
  39. Nakajima F, Tokunaga K, Nakatsuji N. Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy. Stem Cells. 2007;25:983-5 pubmed
    ..Moreover, parthenogenetic hES cell lines can greatly reduce the number required for a higher degree of HLA matching. ..
  40. Mager S, Oomen M, Morente M, Ratcliffe C, Knox K, Kerr D, et al. Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer. 2007;43:828-34 pubmed
    ..These TuBaFrost SOPs could equally be applicable to centres collecting samples for EORTC related translational research studies in order to standardise sample quality and produce reliable and reproducible research results. ..
  41. Brand A, Probst Hensch N. Biobanking for epidemiological research and public health. Pathobiology. 2007;74:227-38 pubmed
  42. Goebel J, Pickardt T, Bedau M, Fuchs M, Lenk C, Paster I, et al. Legal and ethical consequences of international biobanking from a national perspective: the German BMB-EUCoop project. Eur J Hum Genet. 2010;18:522-5 pubmed publisher
  43. Fishman J, Strong D, Kuehnert M. Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank. 2009;10:271-80 pubmed publisher
    ..across the organ and tissue transplantation communities including organ procurement organizations, eye and tissue banks, and transplant infectious disease experts...
  44. Busby H. Biobanks, bioethics and concepts of donated blood in the UK. Sociol Health Illn. 2006;28:850-65 pubmed
  45. Knoppers B. Biobanking: international norms. J Law Med Ethics. 2005;33:7-14 pubmed
  46. Joseph J, Neidich A, Ober C, Ross L. Empirical data about women's attitudes toward a biobank focused on pregnancy outcomes. Am J Med Genet A. 2008;146A:305-11 pubmed publisher
    ..Our survey found widespread willingness to enroll in a pregnancy-focused biobank and optimism that the results will yield significant benefits. ..
  47. Mangia A, Chiriatti A, Chiarappa P, Incalza M, Antonaci G, Pilato B, et al. Touch imprint cytology in tumor tissue banks for the confirmation of neoplastic cellularity and for DNA extraction. Arch Pathol Lab Med. 2008;132:974-8 pubmed publisher
  48. Founti P, Topouzis F, van Koolwijk L, Traverso C, Pfeiffer N, Viswanathan A. Biobanks and the importance of detailed phenotyping: a case study--the European Glaucoma Society GlaucoGENE project. Br J Ophthalmol. 2009;93:577-81 pubmed publisher
    ..Unlike previous biorepositories, this initiative focuses on detailed and standardised phenotyping and is expected to become a major resource for future studies on glaucoma. ..
  49. Furness P, Nicholson M. Obtaining explicit consent for the use of archival tissue samples: practical issues. J Med Ethics. 2004;30:561-4 pubmed
    ..In the UK, the problem of tissue being used against the wishes of the donor has now been largely replaced by the problem of prohibition of tissue use against the wishes of the donor. ..
  50. Moore H, Compton C, Lim M, Vaught J, Christiansen K, Alper J. 2009 Biospecimen research network symposium: advancing cancer research through biospecimen science. Cancer Res. 2009;69:6770-2 pubmed publisher
    ..Biospecimen research represents the kind of bricks-and-mortar research that provides a solid scientific foundation for future advances that will directly help patients. ..
  51. Cavusoglu A, Saydam S, Alakavuklar M, Canda T, Sevinc A, Kilic Y, et al. A pilot study for human tumor/DNA banking: returned more questions than answers. Med Oncol. 2008;25:471-3 pubmed publisher
  52. Hulette C. Brain banking in the United States. J Neuropathol Exp Neurol. 2003;62:715-22 pubmed
    ..Finally, issues surrounding financial support for brain banks will be considered. ..
  53. Riegman P, Dinjens W, Oosterhuis J. Biobanking for interdisciplinary clinical research. Pathobiology. 2007;74:239-44 pubmed
  54. von Wolff M, Donnez J, Hovatta O, Keros V, Maltaris T, Montag M, et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation. Eur J Cancer. 2009;45:1547-53 pubmed publisher
    ..It emphasises that fertility preservation by the cryopreservation of ovarian tissue is a new but already a successful clinical option, which can be considered for selected cancer patients. ..